Cart is empty For adolescents aged 12 to 17 years, most reported adverse events following BNT162b2 vaccination are mild and self-limited, according to a study published online April 21 in Pediatrics.
For adolescents aged 12 to 17 years, most reported adverse events following BNT162b2 vaccination are mild and self-limited, according to a study published online April 21 in Pediatrics.
Leave A Comment